Histopathologically dysplastic neurofibromas in neurofibromatosis 1: diagnostic criteria, prevalence and clinical significance
- 20 March 2008
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 158 (5) , 1008-1012
Abstract
Background Malignant peripheral nerve sheath tumours (MPNSTs) correspond to the most frequent and aggressive neoplasic complications associated with poor prognosis in neurofibromatosis 1. Objectives To define the dysplastic neurofibroma potentially at risk of transformation and evaluate its prevalence and incidence. Methods According to our database, we retrospectively included, between 1 March 2000 and 31 August 2004, all patients who had subcutaneous and/or plexiform neurofibromas removed surgically. Tumour specimens were systematically reviewed; dysplastic neurofibroma was defined by the association of high cellularity and the presence of atypical cells. Clinically atypical and histopathologically dysplastic neurofibromas were analysed using Fisher’s exact test. In addition, three high‐grade MPNSTs were analysed retrospectively for the presence of associated histopathologically dysplastic neurofibroma. Results Among the 89 plexiform and/or subcutaneous neurofibromas surgically removed, high cellularity and cytonuclear atypia were observed in 19% and 17% of cases, respectively. Both criteria were associated in 8·9% of cases (n = 8); Mib‐1 immunostaining was negative in all cases (n = 7). In univariate analysis, only neurological symptoms were significantly associated with dysplasia (P = 0·02). Interestingly, dysplastic neurofibroma areas could be identified within or at the periphery of two MPNSTs. Conclusions The association of hypercellularity and cytonuclear atypia could be considered as a potential histological prognostic factor of transformation leading to increased surveillance.Keywords
This publication has 15 references indexed in Scilit:
- Association between benign and malignant peripheral nerve sheath tumors in NF1Neurology, 2005
- Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1British Journal of Dermatology, 2005
- Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: A cohort study of 703 patientsAmerican Journal of Medical Genetics Part A, 2004
- Molecular Profiles of Neurofibromatosis Type 1-Associated Plexiform NeurofibromasClinical Cancer Research, 2004
- Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCRMolecular Cancer, 2004
- Clinical Risk Factors for Mortality in Patients With Neurofibromatosis 1Archives of Dermatology, 2003
- Malignant peripheral nerve sheath tumours in neurofibromatosis 1Journal of Medical Genetics, 2002
- National Neurofibromatosis Foundation International DatabaseAmerican Journal of Medical Genetics, 1993
- Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 PatientsScience, 1990
- A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutationsCell, 1990